280,16 €
311,29 €
-10% with code: EXTRA
Drug Repurposing
Drug Repurposing
280,16
311,29 €
  • We will send in 10–14 business days.
Drug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, and chemosensitizing human leukemic cells.This book focuses on the hypothesis, risk/benefits, and economic impacts of drug repurposing on drug discovery in dermatology, infectious diseases, neurologica…
  • Publisher:
  • ISBN-10: 1839685204
  • ISBN-13: 9781839685200
  • Format: 17 x 24.4 x 1.4 cm, hardcover
  • Language: English
  • SAVE -10% with code: EXTRA

Drug Repurposing (e-book) (used book) | bookbook.eu

Reviews

Description

Drug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, and chemosensitizing human leukemic cells.This book focuses on the hypothesis, risk/benefits, and economic impacts of drug repurposing on drug discovery in dermatology, infectious diseases, neurological disorders, cancer, and orphan diseases. It brings together up-to-date research to provide readers with an informative, illustrative, and easy-to-read book useful for students, clinicians, and the pharmaceutical industry.

EXTRA 10 % discount with code: EXTRA

280,16
311,29 €
We will send in 10–14 business days.

The promotion ends in 15d.14:16:41

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 3,11 Book Euros!?
  • Publisher:
  • ISBN-10: 1839685204
  • ISBN-13: 9781839685200
  • Format: 17 x 24.4 x 1.4 cm, hardcover
  • Language: English English

Drug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, and chemosensitizing human leukemic cells.This book focuses on the hypothesis, risk/benefits, and economic impacts of drug repurposing on drug discovery in dermatology, infectious diseases, neurological disorders, cancer, and orphan diseases. It brings together up-to-date research to provide readers with an informative, illustrative, and easy-to-read book useful for students, clinicians, and the pharmaceutical industry.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)